We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Hibiscus sabdariffa (Roselle)
Anthocyanin-rich tropical plant with well-documented antihypertensive effects, lipid-lowering properties, and emerging benefits for metabolic health and antioxidant status.
What the evidence says
Most Hibiscus studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2004–2025 with a typical study size of 54 participants.
Based on 28 studies · 9 meta-analyses · 16 RCTs · 993 total participants
Confidence
HighBy outcome
Hibiscus has an evidence score of 5.6/10 — moderate evidence based on 28 indexed studies, including 9 meta-analyses. Anthocyanin-rich tropical plant with well-documented antihypertensive effects, lipid-lowering properties, and emerging benefits for metabolic health and antioxidant status. Representative study: PMID 39870328.
The commonly studied dose of Hibiscus is 250–450 mg standardized extract OR 1.25–2.5 g dried calyx per serving (as tea). Individual needs vary — start at the lower end of the range and adjust based on how you respond.
See full supplement plans that include Hibiscus.
Explore: Best supplements for Vitality & Longevity
Last reviewed June 2026 · evidence from 28 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Hibiscus sabdariffa (roselle, sour tea) is a Malvaceae plant whose dried calyces are rich in anthocyanins, organic acids, and polyphenols. Its best-supported effect is a modest reduction in blood pressure (roughly 5-7 mmHg systolic) in people with elevated or mildly high blood pressure, seen across several meta-analyses — though trial quality is generally low-to-moderate, the highest-certainty review (Cochrane) rated the evidence insufficient, and a head-to-head trial found hibiscus significantly less effective than lisinopril. Lipid evidence is contradictory (some meta-analyses positive, others null), and glycemic effects are small. Proposed mechanisms include mild ACE inhibition, natriuretic/diuretic action, and nitric-oxide-mediated vasodilation. It is usually taken as a brewed tisane or standardized extract, with the clearest benefit in those with higher baseline blood pressure. It is not a substitute for antihypertensive medication.
Hibiscus anthocyanins inhibit angiotensin-converting enzyme (ACE), reducing angiotensin II production and promoting vasodilation. Studies using the renin-angiotensin-aldosterone system (RAAS) markers have confirmed this mechanism in hypertensive patients (PMID:26600645). This accounts for blood pressure reductions comparable to low-dose lisinopril and captopril in clinical trials.
Hibiscus calyces contain high concentrations of anthocyanins and phenolic acids that scavenge reactive oxygen species (ROS) and upregulate endogenous antioxidant enzymes. Human pharmacokinetic data confirm rapid absorption of anthocyanidin-3-glycosides within 2 hours of consumption (PMID:15647413), with measurable increases in systemic antioxidant capacity (PMID:22331521).
Hibiscus polyphenols reduce hepatic lipogenesis, inhibit LDL oxidation, and modestly reduce circulating LDL and total cholesterol. Meta-analyses confirm significant reductions in LDL cholesterol versus placebo and other teas (PMID:34927694). Hibiscus acid and hydroxycitric acid may also inhibit ATP-citrate lyase, reducing fatty acid synthesis.
Hibiscus polyphenols suppress NF-κB signaling, reduce monocyte chemoattractant protein-1 (MCP-1) production, and modulate pro-inflammatory cytokine profiles. A clinical trial confirmed that hibiscus calyx extract significantly reduced MCP-1 in healthy humans (PMID:19765963), while immunomodulatory effects have been reviewed systematically (PMID:34040600).
Hibiscus inhibits α-glucosidase and α-amylase activity, slowing carbohydrate absorption and reducing postprandial glucose excursions. Systemic meta-analysis confirms a significant reduction in fasting plasma glucose (−3.67 mg/dL) with regular consumption (PMID:31943427). Antidiabetic effects have been documented in type 2 diabetic populations (PMID:32156406).
How Hibiscus works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
250–450 mg standardized extract OR 1.25–2.5 g dried calyx per serving (as tea)
Take with food
| Form | Type |
|---|---|
| 💊Standardized extract capsule (anthocyanins ≥10%) | Recommended |
| 🍵Dried calyx tea (2–3 cups/day) | Alternative |
| 💊Hibiscus-inulin combination | Alternative |
Standardized extracts ensure consistent polyphenol content. Tea is traditional and well-studied but variable in potency.
Minimum: 4 weeks
Optimal: 8 weeks
Cycling: Not required
Note: Daily consistency matters more than precise timing. Split dosing (morning and midday/evening with meals) mirrors most RCT protocols.
Dose-response data unavailable. The current published research for Hibiscus does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Consistently reduces systolic BP by 5–10 mmHg and diastolic BP by 3–6 mmHg in hypertensive adults. Effects are most pronounced in those with elevated baseline BP.
Lipid effects are inconsistent — some meta-analyses show modest LDL reduction, others find no significant effect.
Rapid increase in plasma antioxidant capacity within 1–2 hours of consumption, sustained with regular use.
Small but statistically significant reductions in fasting blood glucose, most notable in type 2 diabetic or metabolic syndrome populations.
MCP-1 fell in one acute study, but hs-CRP was not significantly changed across trials/reviews.
Mild natriuretic and diuretic action contributing to blood pressure reduction; comparable to low-dose hydrochlorothiazide in some trials.
Mild nausea, stomach upset, or loose stools reported in some individuals, especially at higher doses.
Avoid therapeutic doses during pregnancy. Hibiscus has demonstrated emmenagogue (uterine-stimulating) effects in animal studies and traditional use; insufficient human safety data. One RCT used a combination including hibiscus for UTI prevention in premature rupture of membranes but this requires medical supervision (PMID:41500088).
Insufficient safety data; avoid high-dose supplementation. Occasional culinary use likely safe.
Limited data in pediatric populations; therapeutic use not recommended without medical supervision.
May be appropriate with monitoring; increased sensitivity to hypotensive effects. Monitor BP and electrolytes due to mild diuretic action.
Use with caution. One RCT showed no significant adverse renal effects at standard doses (PMID:27221151), but diuretic effects and drug interactions warrant monitoring.
High interaction risk — additive BP lowering may cause symptomatic hypotension. Consult physician before use.
Hibiscus acid may chelate dietary non-heme iron. Separate hibiscus from iron-rich meals or iron supplements by at least 2 hours.
Additive blood pressure-lowering effect may cause hypotension. Monitor BP closely and adjust medication under medical supervision.
Hibiscus may reduce simvastatin exposure (increased clearance), potentially lowering its effect; monitor.
Tip: Take with food; reduce dose if symptoms persist
Tip: Monitor blood pressure; avoid combining with antihypertensive medications without supervision
Tip: Usually transient; reduce dose or discontinue if persistent
Tip: Discontinue immediately; seek medical attention for severe reactions
Tip: Normal physiological response; ensure adequate fluid intake
Complementary ACE inhibition and antioxidant mechanisms for blood pressure management
Enhanced antihypertensive effect; both inhibit ACE via different polyphenol pathways
Complementary metabolic pathways — hibiscus addresses BP and LDL; berberine targets glycemic control and AMPK activation
Broader cardiometabolic support across blood pressure, lipids, and glucose
Both support cardiovascular function through different mechanisms — hibiscus via ACE inhibition; hawthorn via improved cardiac contractility and coronary blood flow
Comprehensive cardiovascular support
Quercetin and hibiscus anthocyanins both modulate inflammatory signaling and support endothelial function
Enhanced anti-inflammatory and antioxidant benefits for heart health
Inulin prebiotic fermentation may enhance polyphenol bioavailability and add independent metabolic benefits
Improved lipid-glucose indices in overweight adults as demonstrated in RCT
The best time to take Hibiscus is with meals. Take it with food. Hibiscus anthocyanins are water-soluble and well-absorbed with or without food, but taking with meals reduces the likelihood of GI discomfort.
Hibiscus is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are gastrointestinal discomfort (nausea, loose stools), hypotension, headache. Use caution if any of these apply to you: Hypotension or concurrent antihypertensive medication (additive BP-lowering risk); Allergy to Hibiscus or Malvaceae family plants; Iron-deficiency anemia (may inhibit non-heme iron absorption).
Traditional herb with evidence for supporting testosterone, libido, blood sugar control, and lactation.
Hibiscus may increase the elimination of diclofenac and acetaminophen, potentially reducing their levels.
In vitro data suggest hibiscus calyx extracts modulate CYP1A2 activity, which metabolizes caffeine. Clinical significance at normal doses is likely low (PMID:30951501).